Artificial intelligence is shaping the future of life sciences, offering opportunities to streamline processes, enhance regulatory compliance, and improve operational efficiency. However, despite the potential,

Since founding Generis, James Kelleher has witnessed the company’s transformation from a boutique consultancy into a global leader in content and data management. We caught

With today’s need for speed and efficiency in the life sciences industry, Regulatory Affairs, Pharmacovigilance, Clinical Research, and Quality Management cannot operate as independent islands

Our recent webinar with Remco Munnik, Director at IPERION, a Deloitte Business, Jack Kelleher, Head of Innovation at Generis, and Karolina Rogowska, Head of Marketing

Announced first to customers and partners at our Generate 2024 Conference, former COO Max Kelleher will step up to take the reins as CEO with